Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 18, 2025Open Access

METTL3-mediated m6A modification of DNMT1 enhances ovarian cancer progression

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKanchan KumariIPIván Pérez-NúñezANAleix Noguera

Discussion

Loading...

Member takes

Overview

Study reveals METTL3 modulates DNMT1 levels, enhancing tumor growth in high-grade serous carcinoma.

Key Points

  • Depletion of METTL3 impairs ovarian cancer proliferation and tumor progression, indicating its key role.
  • DNMT1 enhances tumor suppression by silencing genes, showcasing the importance of m6A modification.
  • Pharmacologic inhibition of DNMT1 causes DNA hypomethylation, leading to tumor suppressor upregulation.
  • METTL3-mediated RNA modifications position METTL3 and DNMT1 as promising targets in treating HGSC.

Cite This Study

Kumari et al. (2025) studied this question.

synapsesocial.com/papers/68d435cf713b0b5dfea74fdbhttps://doi.org/10.1101/2025.09.10.675425
View Full Paper
Ask AI
Bookmark
Share